Research analysts at StockNews.com started coverage on shares of Cyren (NASDAQ:CYRN – Get Rating) in a report released on Wednesday. The brokerage set a "hold" rating on the technology company's stock.
Cyren Price Performance
Cyren has a one year low of $0.19 and a one year high of $13.87. The stock has a market cap of $1.70 million, a P/E ratio of -0.04 and a beta of 0.83. The company has a debt-to-equity ratio of 2.30, a current ratio of 1.29 and a quick ratio of 1.29. The business's 50-day moving average price is $0.54 and its two-hundred day moving average price is $0.87.
Get Cyren alerts:Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Nantahala Capital Management LLC bought a new position in shares of Cyren in the third quarter worth $139,000. Millennium Management LLC bought a new stake in shares of Cyren in the 2nd quarter worth approximately $48,000. Virtu Financial LLC bought a new position in shares of Cyren in the first quarter valued at $59,000. Finally, Jane Street Group LLC purchased a new stake in shares of Cyren during the first quarter valued at $426,000. Institutional investors and hedge funds own 23.22% of the company's stock.
About Cyren
(Get Rating)
CYREN Ltd. engages in the provision of cloud delivered Software-as-a-Service cybersecurity solutions that protect businesses, employees and customers against threats from email, files, and the web. It operates through the following geographical segments: Israel, United States, Germany and Other. Its products include inbox security for office 365, threat indepth, and incident response service The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.
Featured Articles
- Get a free copy of the StockNews.com research report on Cyren (CYRN)
- After an Earnings Blowout, Is Ciena Stock a Buying Opportunity?
- Here's Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
- Meta Breaks Out Of A Base, Looks Like A Growth Stock Again
- The Bottom Is In For McCormick & Company
- Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Receive News & Ratings for Cyren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyren and related companies with MarketBeat.com's FREE daily email newsletter.
